Pay in 4 interest-free payments of $5.01 Learn more
Ships within 48 hours · Estimated delivery Sep 9 - Sep 14
lilly tirzepatide vials Releases Zepbound (Tirzepatide) Single-dose Vials, Expanding Supply and Access for Adults Living with Obesity Novo Nordisk launches obesity volume:5mg clinically studied strains
Novo Nordisk launches obesity drug Wegovy in China - The Business Times
Tirzepatide (a dual GLP-1/GIP agonist) achieves 15-22% weight reduction
clinically studied strains
volume:5mg
This news comes as Zepbound outperformed competitors in a weight-loss study and interest in the drug is increasing
US$ 24.64
US$ 25.46
US$ 22.81
US$ 20.26
US$ 27.41
US$ 23.32
US$ 20.25
US$ 27.38
